Azienda Ospedaliera Universitaria Meyer IRCCS

Paediatric Neuro-Oncology

Clinical research at Azienda Ospedaliera Universitaria Meyer IRCCS includes treatment-focused studies in glioblastoma among children and young adults, with attention to chemotherapy combined with radiotherapy and temozolomide.

  • Glioblastoma
  • Anthracycline-based chemotherapy
  • Radiotherapy

These activities reflect a strong interest in paediatric brain tumours and their multimodal treatment pathways.

Embryonal Brain Tumours

The sponsor also supports studies in metastatic medulloblastoma and other embryonal tumours, with clinical focus on craniospinal irradiation and standard or high-dose chemotherapy in younger patients.

  • Medulloblastoma
  • Craniospinal irradiation
  • High-risk embryonal tumours

This area highlights involvement in complex paediatric oncology care for aggressive central nervous system malignancies.

Severe Epilepsy

Another key field is rare disease-associated severe epilepsy in children and young adults, including motor seizures with generalized and focal features.

  • Cannabidiol
  • Anti-seizure medications
  • Seizure burden

The research profile includes interest in adjunctive approaches for difficult-to-control epileptic disorders.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Cannabidiol for Reducing Seizures in Children and Young Adults with Severe Epilepsy Associated with Rare Diseases

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study on the Effects of Doxorubicin and Temozolomide After Radiotherapy in Children and Young Adults with Glioblastoma

    Not recruiting

    1 1 1
    Investigated diseases:
    Italy
  • Study on the Safety and Effectiveness of Methotrexate and Drug Combination for Children and Young Adults with High-Risk Metastatic Medulloblastoma

    Not recruiting

    1 1 1
    Investigated diseases:
    Italy